Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA, 71(3), 209–249. https://doi.org/10.3322/caac.21660
Paluch-Shimon, S., Cardoso, F., Partridge, A. H., Abulkhair, O., Azim, H. A., Jr., Bianchi-Micheli, G., et al. (2020). ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4). Annals of Oncology, 31(6), 674–696. https://doi.org/10.1016/j.annonc.2020.03.284
CAS Article PubMed Google Scholar
Narod, S. A. (2012). Breast cancer in young women. Nature Review Clinical Oncology, 9(8), 460–470. https://doi.org/10.1038/nrclinonc.2012.102
Daly, A. A., Rolph, R., Cutress, R. I., & Copson, E. R. (2021). A review of modifiable risk factors in young women for the prevention of breast cancer. Breast Cancer, 13, 241–257. https://doi.org/10.2147/BCTT.S268401
Article PubMed PubMed Central Google Scholar
Hendrick, R. E., Helvie, M. A., & Monticciolo, D. L. (2021). Breast cancer mortality rates have stopped declining in US women younger than 40 Years. Radiology, 299(1), 143–149.
Ghosh, J., Gupta, S., Desai, S., Shet, T., Radhakrishnan, S., Suryavanshi, P., … Badwe, R. A. (2011). Estrogen, progesterone and HER2 receptor expression in breast tumors of patients, and their usage of HER2-targeted therapy, in a tertiary care centre in India. Indian Journal of Cancer, 48(4), 391–396https://doi.org/10.4103/0019-509X.92245
Cardoso, F., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rubio, I. T., et al. (2019). Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Annals of Oncology, 30(8), 1194–1220. https://doi.org/10.1093/annonc/mdz173
CAS Article PubMed Google Scholar
Bajpai, J., Ventrapati, P., Joshi, S., Wadasadawala, T., Rath, S., Pathak, R., et al. (2021). Unique challenges and outcomes of young women with breast cancers from a tertiary care cancer centre in India. Breast (Edinburgh, Scotland), 60, 177–184. https://doi.org/10.1016/j.breast.2021.09.008
Siegel, R. L., Miller, K. D., & Jemal, A. (2017). Cancer Statistics, 2017. CA, 67(1), 7–30.
Breast cancer incidence (invasive) statistics | Cancer Research UK. (n.d.). Retrieved February 11, 2022, from https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer/incidence-invasive#heading-One
Okazaki, M., Bando, H., Tohno, E., Kujiraoka, Y., Iguchi-Manaka, A., Ichioka, E., … Hara, H. (2021). Investigation of the significance of population-based breast cancer screening among women aged under 40 years. Breast Cancer, 28(1), 75–81https://doi.org/10.1007/s12282-020-01131-x
Nakata, K., Hiyama, E., Katanoda, K., Matsuda, T., Tada, Y., Inoue, M., et al. (2022). Cancer in adolescents and young adults in Japan: Epidemiology and cancer strategy. International Journal of Clinical Oncology, 27(1), 7–15. https://doi.org/10.1007/s10147-021-02064-x
Hayashi, N., Kumamaru, H., Isozumi, U., Aogi, K., Asaga, S., Iijima, K., et al. (2020). Annual report of the Japanese Breast Cancer Registry for 2017. Breast Cancer (Tokyo, Japan), 27(5), 803–809. https://doi.org/10.1007/S12282-020-01139-3
Alvarez-Bañuelos, M. T., Segura-Jaramillo, K. A., Gómez-Rivera, E. D. C., Alarcón-Rojas, C. A., Morales-Romero, J., Sampieri, C. L., et al. (2021). Age under 30 years as a predictor of poor survival in a cohort of mexican women with breast cancer. Cancer Control, 28, 10732748211047408. https://doi.org/10.1177/10732748211047408
Article PubMed PubMed Central Google Scholar
Ntirenganya, F., Twagirumukiza, J. D., Bucyibaruta, G., Rugwizangoga, B., & Rulisa, S. (2021). Premenopausal breast cancer risk factors and associations with molecular subtypes: A case-control study. International Journal of Breast Cancer, 2021, 5560559. https://doi.org/10.1155/2021/5560559
CAS Article PubMed PubMed Central Google Scholar
Chen, L.-J., Chang, Y.-J., & Chang, Y.-J. (2021). Treatment and long-term outcome of breast cancer in very young women: nationwide population-based study. BJS Open, 5(5). https://doi.org/10.1093/bjsopen/zrab087
Conte, B., Soldato, D., Razeti, M. G., Fregatti, P., de Azambuja, E., Schettini, F., … Lambertini, M. (2022). De novo metastatic breast cancer arising in young women: review of the current evidence. Clinical Breast Cancer, 22(1), 78–87https://doi.org/10.1016/j.clbc.2021.10.001
Szollár, A., Újhelyi, M., Polgár, C., Oláh, E., Pukancsik, D., Rubovszky, G., et al. (2019). A long-term retrospective comparative study of the oncological outcomes of 598 very young (≤35 years) and young (36–45 years) breast cancer patients. European Journal of Surgical Oncology, 45(11), 2009–2015. https://doi.org/10.1016/j.ejso.2019.06.007
Suter, M. B., & Pagani, O. (2018). Should age impact breast cancer management in young women? Fine tuning of treatment guidelines. Therapeutic Advances in Medical Oncology, 10, 1758835918776923. https://doi.org/10.1177/1758835918776923
Article PubMed PubMed Central Google Scholar
Azim, H. A. J., & Partridge, A. H. (2014). Biology of breast cancer in young women. Breast Cancer Research : BCR, 16(4), 427. https://doi.org/10.1186/s13058-014-0427-5
Article PubMed PubMed Central Google Scholar
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010). Cancer statistics, 2010. CA, 60(5), 277–300. https://doi.org/10.3322/caac.20073
Hassett, M. J., Hughes, M. E., Niland, J. C., Edge, S. B., Theriault, R. L., Wong, Y.-N., et al. (2008). Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancer. Journal of Clinical Oncology, 26(34), 5553–5560. https://doi.org/10.1200/JCO.2008.17.9705
Article PubMed PubMed Central Google Scholar
Zhong, W., Tan, L., Jiang, W. G., Chen, K., You, N., Sanders, A. J., et al. (2019). Effect of younger age on survival outcomes in T1N0M0 breast cancer: A propensity score matching analysis. Journal of Surgical Oncology, 119(8), 1039–1046. https://doi.org/10.1002/jso.25457
Copson, E., Eccles, B., Maishman, T., Gerty, S., Stanton, L., Cutress, R. I., et al. (2013). Prospective observational study of breast cancer treatment outcomes for UK women aged 18–40 years at diagnosis: The POSH study. Journal of the National Cancer Institute, 105(13), 978–988. https://doi.org/10.1093/jnci/djt134
CAS Article PubMed Google Scholar
Eccles, D., Gerty, S., Simmonds, P., Hammond, V., Ennis, S., & Altman, D. G. (2007). Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH): Study protocol. BMC Cancer, 7, 160. https://doi.org/10.1186/1471-2407-7-160
Article PubMed PubMed Central Google Scholar
Melina Arnold, M., Morgan, E., O’Neill, C., Bardot, A., Walsh, P., Siesling, S., et al. (2021). From early to metastatic breast cancer: A systematic review and meta-analysis of distant recurrence rates. The Breast, 9, S61. https://doi.org/10.1016/S0960-9776(21)00576-2
Lima, S. M., Kehm, R. D., Swett, K., Gonsalves, L., & Terry, M. B. (2020). Trends in parity and breast cancer incidence in US women younger than 40 years from 1935 to 2015. JAMA Network Open, 3(3), e200929. https://doi.org/10.1001/jamanetworkopen.2020.0929
Article PubMed PubMed Central Google Scholar
MacMahon, B., Cole, P., Lin, T. M., Lowe, C. R., Mirra, A. P., Ravnihar, B., et al. (1970). Age at first birth and breast cancer risk. Bulletin of the World Health Organization, 43(2), 209–221.
CAS PubMed PubMed Central Google Scholar
Rosner, B., Colditz, G. A., & Willett, W. C. (1994). Reproductive risk factors in a prospective study of breast cancer: The Nurses’ health study. American Journal of Epidemiology, 139(8), 819–835. https://doi.org/10.1093/oxfordjournals.aje.a117079
CAS Article PubMed Google Scholar
Russo, J., Rivera, R., & Russo, I. H. (1992). Influence of age and parity on the development of the human breast. Breast Cancer Research and Treatment, 23(3), 211–218. https://doi.org/10.1007/BF01833517
CAS Article PubMed Google Scholar
Bonnier, P., Romain, S., Dilhuydy, J. M., Bonichon, F., Julien, J. P., Charpin, C., et al. (1997). Influence of pregnancy on the outcome of breast cancer: A case-control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group. International Journal of Cancer, 72(5), 720–727. https://doi.org/10.1002/(sici)1097-0215(19970904)72:5<720::aid-ijc3>3.0.co;2-u
Muenst, S., Mechera, R., Däster, S., Piscuoglio, S., Ng, C. K. Y., Meier-Abt, F., et al. (2017). Pregnancy at early age is associated with a reduction of progesterone-responsive cells and epithelial Wnt signaling in human breast tissue. Oncotarget, 8(14), 22353–22360. https://doi.org/10.18632/oncotarget.16023
Article PubMed PubMed Central Google Scholar
Brouckaert, O., Rudolph, A., Laenen, A., Keeman, R., Bolla, M. K., Wang, Q., et al. (2017). Reproductive profiles and risk of breast cancer subtypes: A multi-center case-only study. Breast Cancer Research, 19(1), 119. https://doi.org/10.1186/s13058-017-0909-3
CAS Article PubMed PubMed Central Google Scholar
Nguyen, B., Venet, D., Lambertini, M., Desmedt, C., Salgado, R., Horlings, H. M., et al. (2019). Imprint of parity and age at first pregnancy on the genomic landscape of subsequent breast cancer. Breast Cancer Research, 21(1), 25. https://doi.org/10.1186/s13058-019-1111-6
Article PubMed PubMed Central Google Scholar
Asztalos, S., Gann, P. H., Hayes, M. K., Nonn, L., Beam, C. A., Dai, Y., et al. (2010). Gene expression patterns in the human breast after pregnancy. Cancer Prevention Research, 3(3), 301–311. https://doi.org/10.1158/1940-6207.CAPR-09-0069
CAS Article PubMed Google Scholar
Meier-Abt, F., Milani, E., Roloff, T., Brinkhaus, H., Duss, S., Meyer, D. S., et al. (2013). Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. Breast Cancer Research, 15(2), R36. https://doi.org/10.1186/bcr3419
CAS Article PubMed PubMed Central Google Scholar
Russo, J., Balogh, G. A., & Russo, I. H. (2008). Full-term pregnancy induces a specific genomic signature in the human breast. Cancer Epidemiology, Biomarkers & Prevention, 17(1), 51–66. https://doi.org/10.1158/1055-9965.EPI-07-0678
Mauvais-Jarvis, P., Sitruk-Ware, R., & Kuttenn, F. (1982). Luteal phase defect and breast cancer genesis. Breast Cancer Research and Treatment, 2(2), 139–150. https://doi.org/10.1007/BF01806450
CAS Article PubMed Google Scholar
Atashgaran, V., Wrin, J., Barry, S. C., Dasari, P., & Ingman, W. V. (2016). Dissecting the biology of menstrual cycle-associated breast cancer risk. Frontier in Oncology, 6, 267. https://doi.org/10.3389/fonc.2016.00267
Ziegler, R. G., Fuhrman, B. J., Moore, S. C., & Matthews, C. E. (2015). Epidemiologic studies of estrogen metabolism and breast cancer. Steroids, 99(Pt A), 67–75. https://doi.org/10.1016/j.steroids.2015.02.015
CAS Article PubMed PubMed Central Google Scholar
Apter, D., Reinilä, M., & Vihko, R. (1989). Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood. Int J Can, 44(5), 783–787. https://doi.org/10.1002/ijc.2910440506
Russo, J., Tay, L. K., & Russo, I. H. (1982). Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Can Res and Treat, 2(1), 5–73. https://doi.org/10.1007/BF01805718
Emaus, A., Espetvedt, S., Veierød, M. B., Ballard-Barbash, R., Furberg,
留言 (0)